Advertisement
Screener

SIGYN THERAPEUTICS, INC. (SIGY) Convertible Notes Payable

2.8 / 5 stars · 68/120 Roast Me

SIGYN THERAPEUTICS, INC. Convertible Notes Payable

SIGYN THERAPEUTICS, INC. (SIGY) had Convertible Notes Payable of $3.55 million as of 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes Payable

us-gaap:ConvertibleNotesPayable · last filed 2025-11-14

  • 2025-09-30: Convertible Notes Payable $3.55M.
  • 2025-06-30: Convertible Notes Payable $2.49M.
  • 2025-03-31: Convertible Notes Payable $2.40M.
  • 2024-12-31: Convertible Notes Payable $2.02M.
Period endConvertible Notes PayableConvertible Notes Payable as first filed
2025-09-30$3.55M
10-Q · filed 2025-11-14
2025-06-30$2.49M
10-Q · filed 2025-09-05
2025-03-31$2.40M
10-Q · filed 2025-05-20
2024-12-31$2.02M
10-Q · filed 2025-11-14
2024-09-30$2.00M
10-Q · filed 2024-11-19
2024-06-30$2.01M
10-Q · filed 2024-08-19
2024-03-31$2.78M
10-Q · filed 2024-05-14
2023-12-31$2.51M
10-Q · filed 2025-11-14
2023-09-30$3.79M
10-Q · filed 2023-11-14
2023-06-30$3.05M
10-Q · filed 2023-08-14
2023-03-31$3.25M
10-Q · filed 2023-05-15
2022-12-31$2.28M
10-Q · filed 2025-05-20
2022-09-30$1.92M
10-Q · filed 2022-11-14
2022-06-30$1.28M
10-Q · filed 2022-08-15
2022-03-31$920.82K
10-Q · filed 2022-05-13
2021-12-31$700.82K
10-K · filed 2024-02-20
2021-09-30$731.50K
10-Q · filed 2021-11-12
2021-06-30$726.50K
10-Q · filed 2021-08-16
2021-03-31$836.50K
10-Q · filed 2021-05-17
2020-12-31$616.50K
10-K · filed 2023-03-31
2020-09-30$849.58K
8-K/A · filed 2020-12-30
$1.80M
10-Q · filed 2020-11-09
2020-06-30$1.80M
10-Q · filed 2020-08-07
2020-03-31$1.80M
10-Q · filed 2020-05-15
2019-12-31$1.80M
10-Q · filed 2020-11-09
2019-09-30$1.77M
10-Q · filed 2019-11-12
2019-06-30$1.73M
10-Q · filed 2019-08-05
2019-03-31$1.73M
10-Q · filed 2019-04-19
2018-12-31$1.73M
10-K · filed 2020-03-30
2018-09-30$1.73M
10-Q · filed 2018-11-14
2018-06-30$1.73M
10-Q · filed 2018-08-13
2018-03-31$1.73M
10-Q · filed 2018-05-15
2017-12-31$1.44M
10-K · filed 2019-04-01